Although little is known about the regulatory mechanism of CD30 surface expression in CTCL, constitutive signaling via JAK/STAT might indeed confer one possible method to upregulate CD30 expression in MF due to STAT-responsive elements within the CD30 promotor [56]. Here, SOAT1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.